Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 studyG. Martin de Frémont, Antoine Baudet, Vincent Sobanski et al.|The Lancet Rheumatology|2023Cited by 37
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsRenaud Felten, Jacques‐Eric Gottenberg, Pierre‐Marie Duret et al.|Annals of the Rheumatic Diseases|2021Cited by 20
Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016–2017Pauline Richebé, Raphaèle Séror, Guillaume Coiffier et al.|Annals of the Rheumatic Diseases|2022Cited by 13
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritidesRenaud Felten, Jean-Hugues Salmon, M. Geoffroy et al.|Joint Bone Spine|2022Cited by 1
Comment on: Hydroxychloroquine levels in pregnancy and materno–fetal outcomes in Systemic Lupus Erythematosus patients: ReplyGelsomina Alle, C. Durant, G. Guettrot-Imbert et al.|Lara D. Veeken|2024Cited by 1